foxo4-dri senolytic peptide human trials Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI UK | Senolytic Peptide
Description
The active ingredients of supplements, i.e
Advertncias
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION
BPC-157 + TB4-Frag is a combination of the distinct bioactive fragment (Ac-SDKP) of the naturally occurring peptide Thymosin Beta-4 Frag and BPC-157 as BPC-157 arginate with salcaprozate sodium (SNAC) for enhanced absorption
